|
|
|
Volumn 162, Issue 1, 2000, Pages
|
|
Reference-based pricing.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
CANADA;
COST BENEFIT ANALYSIS;
COST CONTROL;
DRUG COST;
DRUG USE;
ECONOMICS;
HUMAN;
HYPERTENSION;
NOTE;
PHARMACOKINETICS;
REPRODUCIBILITY;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CANADA;
COST CONTROL;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUG UTILIZATION REVIEW;
HUMANS;
HYPERTENSION;
REPRODUCIBILITY OF RESULTS;
THERAPEUTIC EQUIVALENCY;
|
|
EID: 0034635105
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
